Literature DB >> 1595076

Risk indicators after envenomation in humans by Echis coloratus (mid-east saw scaled viper).

A Porath1, D Gilon, H Schulchynska-Castel, O Shalev, A Keynan, J Benbassat.   

Abstract

To determine the frequency, severity and predictors of bleeding and azotemia after envenomation in humans by Echis coloratus, a retrospective survey of 68 cases in Israel between 1970 and 1989 was carried out. We used univariate and multivariate analyses of clinical variables on admission for the outcome variables of bleeding, hemoglobin and platelet levels, and blood urea. Within hours or days after envenomation, a major bleeding episode occurred in 18% of the victims, a drop in hemoglobin to 10 g/dliter or less in 14%, and an increase in blood urea to 9 mmole/liter or more in 15%. These complications correlated with time interval between envenomation and hospital admission, and the following admission variables: degree of bleeding, hemoglobin level, platelet and white blood cell counts, blood urea and proteinuria. Complications were unlikely in patients who were presented with all of the following: a hemoglobin level of 13 g/dliter or more, a platelet count of 100,000/mm3 or more, a blood urea level of 7 mmole/liter or less, no proteinuria and no bleeding. Treatment on admission with a specific monovalent antiserum was associated with a shorter duration of hemostatic failure and a reduced incidence of anemia and thrombopenia. Infusion of fresh frozen plasma on admission did not appear to be effective in preventing complications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595076     DOI: 10.1016/0041-0101(92)90498-t

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  5 in total

1.  Clotting factor replacement and recovery from snake venom-induced consumptive coagulopathy.

Authors:  Simon G A Brown; Ngaire Caruso; Meredith L Borland; David L McCoubrie; Antonio Celenza; Geoffrey K Isbister
Journal:  Intensive Care Med       Date:  2009-06-23       Impact factor: 17.440

2.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

3.  A randomized controlled trial of fresh frozen plasma for coagulopathy in Russell's viper (Daboia russelii) envenoming.

Authors:  G K Isbister; S Jayamanne; F Mohamed; A H Dawson; K Maduwage; I Gawarammana; D G Lalloo; H J de Silva; F E Scorgie; L F Lincz; N A Buckley
Journal:  J Thromb Haemost       Date:  2017-02-16       Impact factor: 5.824

Review 4.  Novel Treatment Strategy for Patients with Venom-Induced Consumptive Coagulopathy from a Pit Viper Bite.

Authors:  Eun Jung Park; Sangchun Choi; Hyuk-Hoon Kim; Yoon Seok Jung
Journal:  Toxins (Basel)       Date:  2020-05-05       Impact factor: 4.546

Review 5.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.